A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : SARS-CoV-2

検索条件

検索語：SARS-CoV-2

検索方法：完全一致

主な研究分野:

結果

略語: SARS-CoV-2

出現頻度: 34575

対応する展開形の数: 98

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

severe acute respiratory syndrome coronavirus 2

(33759回)

Medicine

医学, 医薬

(3029回)

COVID-19(15388回)

ACE2(1831回)

RT-PCR(1163回)

2013The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection.

syndrome coronavirus 2

(461回)

Medicine

医学, 医薬

(40回)

COVID-19(197回)

ACE2(32回)

ICU(14回)

2020Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.

SARS coronavirus 2

(193回)

Medicine

医学, 医薬

(19回)

COVID-19(62回)

SARS(30回)

ACE2(27回)

2020SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

syndrome coronavirus 2 infection

(15回)

Communicable Diseases

伝染病

(2回)

COVID-19(4回)

CI(3回)

ICU(3回)

2020SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with a favourable outcome.

Since December 2019, a novel coronavirus

(11回)

Medicine

医学, 医薬

(2回)

ARDS(1回)

AUC(1回)

BMI(1回)

2020The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.

Sequence of a 2019 Novel Coronavirus

(8回)

Microbiological Phenomena

(5回)

COVID-19(3回)

HLH(1回)

2020Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.

severe acute syndrome coronavirus 2

(7回)

Immune System Diseases

(2回)

ACE2(3回)

ANMS(1回)

ATII(1回)

2020Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.

severe acute coronavirus 2

(5回)

Pediatrics

小児科学, 小児医学

(2回)

COVID-19(3回)

CI(1回)

crASI(1回)

2020Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain.

syndrome-corona virus 2

(5回)

Public Health

公衆衛生, 公衆衛生学

(1回)

COVID-19(1回)

LMWH(1回)

N-protein(1回)

2020COVID-19, coagulopathy and venous thromboembolism: more questions than answers.

SARS-associated coronavirus 2

(4回)

Physiology

生理学

(1回)

COVID-19(2回)

ACE2(1回)

ARDS(1回)

2021The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19.

severe acute coronavirus type 2

(3回)

Medicine

医学, 医薬

(1回)

II(1回)

AUROC(1回)

COVID-19(1回)

2021From Health Disparities to Hotspots to Public Health Strategies: The Impact of the COVID-19 Pandemic in North Carolina.

syndrome-related to coronavirus 2

(3回)

Pulmonary Medicine

呼吸器学, 呼吸器内科学, 呼吸器科学, 呼吸器医学

(1回)

COVID-19(3回)

HCWs(1回)

LTRs(1回)

2020Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.

secondary to coronavirus 2

(3回)

Occupational Health

(1回)

ARDS(1回)

COVID-19(1回)

ECMO(1回)

2020Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).

such as corona virus-2

(3回)

Pharmacology

薬理学, 薬理, 薬品作用学

(2回)

CUR(1回)

EGCG(1回)

HIV(1回)

2020A Systems Approach to Assess Transport and Diffusion of Hazardous Airborne Particles in a Large Surgical Suite: Potential Impacts on Viral Airborne Transmission.

severe coronavirus 2

(3回)

Medicine

医学, 医薬

(1回)

OMS(1回)

plasma(1回)

2022Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19.

Since 2019, the novel coronavirus

(2回)

Chemical Phenomena

(1回)

ACovPs(1回)

AMPs(1回)

COVID-19(1回)

2022A database of anti-coronavirus peptides.

Subsequently, coronavirus 2

(2回)

Medicine

医学, 医薬

(2回)

IL(2回)

COVID-19(1回)

2020COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

syndrome coronavirus disease 2019

(2回)

Public Health

公衆衛生, 公衆衛生学

(1回)

COVID-19(1回)

CSF(1回)

ICU(1回)

2021The Main Issues and Challenges Older Adults Face in the SARS-CoV-2 Pandemic: A Scoping Review of Literature.

severe acute coronavirus 2 syndrome

(2回)

Chemistry, Pharmaceutical

(1回)

COVID-19(2回)

RdRp(1回)

WHO(1回)

2022One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein.

severe acute respiratory infections caused by 2019 novel coronavirus

(2回)

Allergy and Immunology

アレルギー・免疫

(1回)

2020Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).